219 related articles for article (PubMed ID: 1923365)
1. Oscillatory potentials and permeability of the blood-retinal barrier in noninsulin-dependent diabetic patients without retinopathy.
Yoshida A; Kojima M; Ogasawara H; Ishiko S
Ophthalmology; 1991 Aug; 98(8):1266-71. PubMed ID: 1923365
[TBL] [Abstract][Full Text] [Related]
2. Inward and outward permeability of the blood-retinal barrier in experimental myopia.
Yoshida A; Ishiko S; Kojima M
Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S239-42. PubMed ID: 8871181
[TBL] [Abstract][Full Text] [Related]
3. Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous.
Lobo CL; Bernardes RC; Santos FJ; Cunha-Vaz JG
Arch Ophthalmol; 1999 May; 117(5):631-7. PubMed ID: 10326960
[TBL] [Abstract][Full Text] [Related]
4. Long-term kinetic vitreous fluorophotometry in normal and diabetic subjects.
Knudsen LL; Olsen T; Nielsen-Kudsk F
Acta Ophthalmol (Copenh); 1992 Oct; 70(5):570-7. PubMed ID: 1471478
[TBL] [Abstract][Full Text] [Related]
5. Estimation of permeability in blood-retinal barrier.
Kojima M; Yoshida A; Ishiko S; Tanaka K
Hokkaido Igaku Zasshi; 1990 Jul; 65(4):419-27. PubMed ID: 2227794
[TBL] [Abstract][Full Text] [Related]
6. Fluorescein transport across the human blood-retina barrier in the direction vitreous to blood. Quantitative assessment in vivo.
Engler CB; Sander B; Larsen M; Dalgaard P; Lund-Andersen H
Acta Ophthalmol (Copenh); 1994 Dec; 72(6):655-62. PubMed ID: 7747570
[TBL] [Abstract][Full Text] [Related]
7. The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry.
Schalnus R; Ohrloff C
Ophthalmic Res; 1995; 27 Suppl 1():116-23. PubMed ID: 8577448
[TBL] [Abstract][Full Text] [Related]
8. [Permeability of the blood-ocular barrier in diabetics without retinopathy].
Yoshida A; Kojima M; Nara Y; Ohta I
Nippon Ganka Gakkai Zasshi; 1988 Jun; 92(6):1016-20. PubMed ID: 3189073
[No Abstract] [Full Text] [Related]
9. Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry.
Schalnus R; Ohrloff C; Jungmann E; Maass K; Rinke S; Wagner A
Ger J Ophthalmol; 1993 Aug; 2(4-5):202-6. PubMed ID: 8220099
[TBL] [Abstract][Full Text] [Related]
10. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.
Lobo CL; Bernardes RC; Figueira JP; de Abreu JR; Cunha-Vaz JG
Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598
[TBL] [Abstract][Full Text] [Related]
11. Posterior vitreous fluorophotometry in diabetic patients with minimal or no retinopathy.
Roy MS; Podgor MJ; Bungay P; Grunberger G; Carl J; Ellis D
Retina; 1987; 7(3):170-6. PubMed ID: 3423432
[TBL] [Abstract][Full Text] [Related]
12. Fluorometric evaluation of panretinal photocoagulation in diabetic subjects.
Knudsen LL; Olsen T; Nielsen-Kudsk F
Acta Ophthalmol Scand; 1997 Aug; 75(4):393-7. PubMed ID: 9374246
[TBL] [Abstract][Full Text] [Related]
13. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
Retina; 1995; 15(2):134-40. PubMed ID: 7624601
[TBL] [Abstract][Full Text] [Related]
14. Differential spectrofluorometry in the human vitreous: blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
Larsen M; Dalgaard P; Lund-Andersen H
Graefes Arch Clin Exp Ophthalmol; 1991; 229(4):350-7. PubMed ID: 1916323
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility of vitreous fluorophotometry in patients with type 1 diabetes mellitus.
Jager J; Tromp A; Hooymans JM; Reitsma WD; Smit AJ
Ophthalmologica; 1997; 211(4):209-13. PubMed ID: 9216008
[TBL] [Abstract][Full Text] [Related]
16. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.
Chahal P; Fallon TJ; Jennings SJ; Chowienczyk PJ; Kohner EM
Diabetes Care; 1986; 9(2):134-9. PubMed ID: 3698779
[TBL] [Abstract][Full Text] [Related]
17. Effect of morphological abnormalities on blood retinal barrier permeability in diabetic retinopathy.
van Gerven JM; Boot JP; Lemkes HH; van Best JA
Doc Ophthalmol; 1992; 80(2):183-8. PubMed ID: 1425133
[TBL] [Abstract][Full Text] [Related]
18. Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine.
Nuzzi G; Venturini I; De Gregorio M; Arsenio L; Maraini G
Acta Ophthalmol Scand; 1997 Feb; 75(1):41-3. PubMed ID: 9088399
[TBL] [Abstract][Full Text] [Related]
19. Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes.
Do carmo A; Ramos P; Reis A; Proença R; Cunha-vaz JG
Exp Eye Res; 1998 Nov; 67(5):569-75. PubMed ID: 9878219
[TBL] [Abstract][Full Text] [Related]
20. Blood-retina barrier in acute retinal branch vein occlusion.
Silva RM; Faria de Abreu JR; Cunha-Vaz JG
Graefes Arch Clin Exp Ophthalmol; 1995 Nov; 233(11):721-6. PubMed ID: 8566831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
